AML hematology
In the spotlights
The role of Measurable Residual Disease (MRD) testing in the treatment of Acute Myeloide Leukemia (AML)
Events & Congresses
Materials
The role of Measurable Residual Disease (MRD) testing in the treatment of Acute Myeloide Leukemia (AML)
Video
FULL VIDEO
In this video, experts Prof. Dr. Jacqueline Cloos and Dr. Peter Valk, discuss the role of MRD (Measurable Residual Disease) testing in the treatment of AML (Acute Myeloide Leukemia)...
The AML landscape
Video
BLOCK 1
Experts Prof. Dr. Jacqueline Cloos and Dr. Peter Valk provide an overview of the current AML research and treatment landscape...
Flowcytometry for MRD detection in AML
Video
BLOCK 2
Prof. Dr. Jacqueline Cloos is presenting the flowcytometry technique, and explains which flowcytometry methods can be used...
Molecular MRD detection in AM
Video
BLOCK 3
Dr. Peter Valk presents the molecular MRD technique and explains how and why this technique is used in AML treatment...
Recent MRD-AML studies
Video
BLOCK 4
Prof. Dr. Jacqueline Cloos and Dr. Valk summarize two highlighted and recently published articles about MRD-guided therapy...
The unmet needs and future challenges and developments in the treatment of AML
Video
BLOCK 5
Prof. Dr. Jacqueline Cloos and Dr. Valk give their opinion about the unmet needs in the treatment of AML ...
XOSPATA patient brochure
Information about treatment with gilteritinib. It does not replace the package leaflet.
Read more